A great deal of publicity and controversy surrounds the potential health impacts associated with the use of products containing Bisphenol-A (BPA). Although scientific evidence regarding the health impacts of exposure to BPA on humans is limited, legislators and administrative agencies at various levels of government both within the United States and abroad have begun to focus attention on the manufacture, sale and consumption of BPA.
In this webinar, we offer a comprehensive analysis of the science surrounding BPA concerns as well as the current status and trends regarding federal and state litigation involving BPA-containing products. We will also cover strategies for defending against this wave of litigation and the impact that current and future government regulation may have on the litigation landscape. Craig A. Woods and Michael A. Olsen, partners in Mayer Brown's Litigation practice will host the presentation along with James C. Lamb, IV, a principal with Exponent Consulting.
Learn more about Mayer Brown's Chemicals practice.
Learn more about Exponent at exponent.com